Syon Capital’s Bristol-Myers Squibb BMY Stock Holding History

Syon Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$873K	Buy	14,395 +1,085	+8%	+$63.3K	0.04%	342
2025 Q4	$718K	Buy	13,310 +2,072	+18%	+$99.7K	0.04%	418
2025 Q3	$507K	Sell	11,238 -1,164	-9%	-$54.4K	0.03%	493
2025 Q2	$574K	Sell	12,402 -4,622	-27%	-$227K	0.04%	329
2025 Q1	$1.04M	Buy	17,024 +1,042	+7%	+$60.7K	0.08%	175
2024 Q4	$904K	Buy	15,982 +4,335	+37%	+$242K	0.08%	176
2024 Q3	$603K	Buy	11,647 +1,407	+14%	+$66K	0.05%	241
2024 Q2	$425K	Sell	10,240 -12,461	-55%	-$558K	0.04%	286
2024 Q1	$1.23M	Sell	22,701 -4,149	-15%	-$211K	0.12%	127
2023 Q4	$1.38M	Buy	26,850 +19,998	+292%	+$1.05M	0.06%	197
2023 Q3	$398K	Buy	+6,852	New	+$420K	0.05%	220

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Syon Capital's BMY Position: Q1 2026 in Review

Syon Capital increased its Bristol-Myers Squibb (BMY) stake by 8.2% in Q1 2026, buying an estimated $63.3K and bringing the position to 14,395 shares worth $873K. The position accounts for 0.04% of the portfolio, ranked #342.

Syon Capital first reported a position in BMY in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.38M in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Syon Capital held 14,395 shares of Bristol-Myers Squibb worth $873K as of Q1 2026.
Syon Capital bought 1,085 Bristol-Myers Squibb shares in Q1 2026, an estimated $63.3K.
Bristol-Myers Squibb made up 0.04% of Syon Capital's portfolio in Q1 2026, its #342 holding.
Syon Capital first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 11 quarters since.
Syon Capital's Bristol-Myers Squibb position peaked at $1.38M in Q4 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.